Research and Deveplopment Landscape and Industry Trends of Blood Product Enterprises in China and Abroad
10.3870/j.issn.1004-0781.2025.08.013
- VernacularTitle:国内外血液制品企业产品研发现状及产业发展态势
- Author:
Yanan XU
1
;
Jiping HUO
;
Qiang WU
;
Ding YU
;
Hong LIANG
;
Rui FU
;
Wenli MA
;
Wei ZHANG
;
Zhigang ZHAO
Author Information
1. 首都医科大学附属北京天坛医院药学部,北京 100070;首都医科大学药学院,北京 100069
- Publication Type:Journal Article
- Keywords:
Blood products;
Immunoglobulins;
Coagulation factors;
Recombinant plasma protein;
Research and development;
Clinical trial
- From:
Herald of Medicine
2025;44(8):1272-1280
- CountryChina
- Language:Chinese
-
Abstract:
The blood products industry,both domestically and internationally,exhibits distinct features in product research,development,and technological innovation.International companies possess extensive expertise in developing immunoglobulins,coagulation factors,and recombinant plasma protein products,demonstrating continuous advancements-particularly in specific immunoglobulin development,long-acting formulation optimization,and manufacturing process improvements.In recent years,Chinese enterprises have also achieved notable progress in related fields,especially in immunoglobulin process refinement and the development of novel recombinant coagulation factor products.However,there remains significant scope for improvement in areas such as the application of recombinant protein technologies,efficient utilization of plasma resources,and the adoption of advanced manufacturing techniques.Additional challenges include the accumulation of patented technologies,the supply of critical raw materials,and access to comprehensive epidemiological data.Driven by ongoing advances in gene recombination technologies,innovations in drug delivery systems,digital transformation,and the rise of personalized medicine,the blood products industry is poised for broader development prospects.To foster sustained and stable domestic industry growth and enhance global competitiveness,Chinese blood product enterprises should intensify their technological accumulation,upgrade manufacturing processes,and optimize plasma resource utilization.
